Lin Jia
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Angiogenesis and VEGF in Cancer 8
- RNA modifications and cancer 8
- RNA Research and Splicing 5
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 6
- Co-authors
- Yan Fu (11 shared papers)Andrew R. Hoffman (9 shared papers)Ji‐Fan Hu (8 shared papers)Jiuwei Cui (14 shared papers)Naifei Chen (10 shared papers)Shu-Man Jiang (12 shared papers)Sai Wah Tsao (6 shared papers)Lei Zhou (8 shared papers)
- Journals
- World Journal of Gastroenterology (6 papers)The Journal of Pathology (4 papers)Digestion (4 papers)Digestive and Liver Disease (4 papers)Oncogene (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lin Jia
95 papers receiving 3.1k citations
Lin Jia's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 808
- Oncology 898
- Molecular Biology 1.5k
- Immunology 364
- Gastroenterology 79
Countries citing papers authored by Lin Jia
This map shows the geographic impact of Lin Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jia more than expected).
Fields of papers citing papers by Lin Jia
This network shows the impact of papers produced by Lin Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jia. The network helps show where Lin Jia may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Jia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study Hit paper breakdown → | 2018 | 485 |
| 2 | 2018 | 334 | |
| 3 | 2017 | 209 | |
| 4 | 2021 | 96 | |
| 5 | 2012 | 96 | |
| 6 | 2017 | 90 | |
| 7 | 2014 | 86 | |
| 8 | 2007 | 73 | |
| 9 | 2016 | 56 | |
| 10 | 2019 | 56 | |
| 11 | 2010 | 54 | |
| 12 | 2014 | 54 | |
| 13 | 2020 | 51 | |
| 14 | 2023 | 49 | |
| 15 | 2018 | 48 | |
| 16 | 2022 | 46 | |
| 17 | 2014 | 46 | |
| 18 | 2015 | 41 | |
| 19 | 2005 | 41 | |
| 20 | Genome-wide target interactome profiling reveals a novel EEF1A1 epigenetic pathway for oncogenic lncRNA MALAT1 in breast cancer. | 2019 | 41 |
About Lin Jia
Lin Jia is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 97 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), Angiogenesis and VEGF in Cancer (8 papers), Pancreatitis Pathology and Treatment (8 papers), RNA modifications and cancer (8 papers), Viral-associated cancers and disorders (7 papers), MicroRNA in disease regulation (6 papers), Gastrointestinal motility and disorders (5 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Cancer Research (808 citations), Oncology (898 citations), Molecular Biology (1.5k citations), Immunology (364 citations) and Gastroenterology (79 citations). Lin Jia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yan Fu, Andrew R. Hoffman, Ji‐Fan Hu, Jiuwei Cui, Naifei Chen, Shu-Man Jiang, Sai Wah Tsao, Lei Zhou, Nan Song and Xin‐an Lu. Their work appears in journals such as World Journal of Gastroenterology, The Journal of Pathology, Digestion, Digestive and Liver Disease and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.